GlassScriptPhysician profile
Dallen Shane Pope
NPI 1578058962
$4,980.56
in general payments reported to CMS, 2019-2025
14 companies · $26.10 in 2025
The $26.10 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,196 · 2020: $983 · 2021: $80.28 · 2022: $98.77 · 2023: $2,576 · 2024: $20.39 · 2025: $26.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,350 · Food and Beverage: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,349.66 |
| Food and Beverage | $272.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cornerstone Medical Associates, INC. | $1,960.19 | 2023 | |
| Stryker Corporation | $953.06 | 2019-2020 | |
| Wardlow Enterprises | $794.11 | 2020 | |
| Arthrex, INC. | $462.48 | 2023 | |
| Paragon 28, INC. | $208.38 | 2022-2024 | Grappler, Portfolio |
| Depuy Synthes Sales INC. | $157.72 | 2019-2020 | |
| Wright Medical Technology, INC. | $121.93 | 2019 | |
| Zimmer Biomet Holdings, INC. | $83.55 | 2019-2021 | |
| Smith+Nephew, INC. | $76.33 | 2021-2025 | Regranex, Collagenase Santyl |
| Treace Medical Concepts, INC. | $49.62 | 2023 | |
| Next Science LLC | $47.74 | 2020 | |
| Integra Lifesciences Corporation | $26.82 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $22.03 | 2020 | |
| Organogenesis INC. | $16.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dallen Pope listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.